Victory Capital Management’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.9K | Buy |
25,492
+6,475
| +34% | +$15K | ﹤0.01% | 2368 |
|
|
2025
Q1 | $26.4K | Buy |
19,017
+16
| +0.1% | +$22 | ﹤0.01% | 2414 |
|
|
2024
Q4 | $32.9K | Sell |
19,001
-1,006
| -5% | -$1.74K | ﹤0.01% | 2424 |
|
|
2024
Q3 | $40.2K | Buy |
20,007
+1,945
| +11% | +$3.91K | ﹤0.01% | 2405 |
|
|
2024
Q2 | $40.5K | Buy |
18,062
+1,144
| +7% | +$2.56K | ﹤0.01% | 2386 |
|
|
2024
Q1 | $48.6K | Buy |
16,918
+1,318
| +8% | +$3.78K | ﹤0.01% | 2381 |
|
|
2023
Q4 | $27.6K | Buy |
+15,600
| New | +$27.6K | ﹤0.01% | 2489 |
|